Pharmaceuticals

Livzon is a comprehensive pharmaceutical enterprise integrating development & research, production and sales of pharmaceutical products, ranking 9 at Top 50 Pharmaceutical companies in China, ranking 8 at Top 10 listed pharmaceutical companies with the highest R&D investment. Livzon Group API Division established June 2015, is dedicated in the R&D, manufacturing and sales of API, including 4 manufacturing sites, Livzon Fuzhou Fuxing, Livzon New North River, Livzon Ningxia and Livzon Syntpharm. Most of the manufacturing sites have been approved by US FDA. And most of the products in regulatory markets have obtained CEP.

Thanks to the experience gained through over seventy years of work, A. Constantino & C. S.p.A. is today numbered among the world's largest producers of raw materials of animal and vegetable origin or top- level pharmaceutical use. Over the years, the company's horizons have expanded beyond national frontiers, and clients today include some of the world's best-known pharmaceutical companies. This expansion has also enabled the company to broaden its range of production, today comprising the categories enzymes for pharmaceutical and industrial use, animal organ extracts for pharmaceutical use, peptones and protein hydrolysates for industrial fermentation and for microbiology. A vital factor running right through A. Costantino & C. S.p.A.'s success story has been the emphasis the company has always placed on quality products. In 1997 this policy was rewarded by Quality Certification to the ISO 9001:2008 (Certiquality) nr.1086. For A. Costantino & C. S.p.A., the search for quality does not only mean successfully meeting market demands, rather that the company is continually renewed and updated, seeking to offer clients a product of high technological standard and service in line with their highly specific needs, as well as guaranteeing constant quality